Diasorin SpA (LTS:0GZX) Short-Term Debt : €52 Mil (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Short-Term Debt?

Diasorin SpA's Short-Term Debt for the quarter that ended in Jun. 2024 was €52 Mil.

Diasorin SpA's quarterly Short-Term Debt declined from Dec. 2023 (€101 Mil) to Mar. 2024 (€0 Mil) but then increased from Mar. 2024 (€0 Mil) to Jun. 2024 (€52 Mil).

Diasorin SpA's annual Short-Term Debt increased from Dec. 2021 (€91 Mil) to Dec. 2022 (€112 Mil) but then declined from Dec. 2022 (€112 Mil) to Dec. 2023 (€101 Mil).

Diasorin SpA Short-Term Debt Historical Data

The historical data trend for Diasorin SpA's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Short-Term Debt Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

90.77

111.52

100.74

Diasorin SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	100.74	-	51.51	-

Diasorin SpA Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Diasorin SpA Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

DIA:Italy DIAm:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines